Logo image of TM

TOYOTA MOTOR CORP -SPON ADR (TM) Stock Fundamental Analysis

USA - NYSE:TM - US8923313071 - ADR

198.78 USD
+1.5 (+0.76%)
Last: 9/16/2025, 8:04:00 PM
200 USD
+1.22 (+0.61%)
After Hours: 9/16/2025, 8:04:00 PM
Fundamental Rating

6

Taking everything into account, TM scores 6 out of 10 in our fundamental rating. TM was compared to 37 industry peers in the Automobiles industry. While TM has a great profitability rating, there are some minor concerns on its financial health. TM has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

TM had positive earnings in the past year.
TM had a positive operating cash flow in the past year.
TM had positive earnings in each of the past 5 years.
In the past 5 years TM always reported a positive cash flow from operatings.
TM Yearly Net Income VS EBIT VS OCF VS FCFTM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2T 4T

1.2 Ratios

TM has a better Return On Assets (4.57%) than 91.89% of its industry peers.
TM's Return On Equity of 11.86% is amongst the best of the industry. TM outperforms 97.30% of its industry peers.
Looking at the Return On Invested Capital, with a value of 5.35%, TM belongs to the top of the industry, outperforming 94.59% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for TM is in line with the industry average of 5.63%.
The last Return On Invested Capital (5.35%) for TM is above the 3 year average (4.89%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.57%
ROE 11.86%
ROIC 5.35%
ROA(3y)4.63%
ROA(5y)4.34%
ROE(3y)12.12%
ROE(5y)11.36%
ROIC(3y)4.89%
ROIC(5y)4.54%
TM Yearly ROA, ROE, ROICTM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10

1.3 Margins

Looking at the Profit Margin, with a value of 8.82%, TM belongs to the top of the industry, outperforming 97.30% of the companies in the same industry.
TM's Profit Margin has improved in the last couple of years.
TM has a Operating Margin of 9.60%. This is amongst the best in the industry. TM outperforms 97.30% of its industry peers.
TM's Operating Margin has improved in the last couple of years.
With a decent Gross Margin value of 19.29%, TM is doing good in the industry, outperforming 78.38% of the companies in the same industry.
TM's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 9.6%
PM (TTM) 8.82%
GM 19.29%
OM growth 3Y1.5%
OM growth 5Y4.44%
PM growth 3Y2.98%
PM growth 5Y7.79%
GM growth 3Y1.57%
GM growth 5Y2.05%
TM Yearly Profit, Operating, Gross MarginsTM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), TM is creating some value.
The number of shares outstanding for TM has been reduced compared to 1 year ago.
TM has less shares outstanding than it did 5 years ago.
TM has a worse debt/assets ratio than last year.
TM Yearly Shares OutstandingTM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
TM Yearly Total Debt VS Total AssetsTM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20T 40T 60T 80T

2.2 Solvency

TM has an Altman-Z score of 1.72. This is a bad value and indicates that TM is not financially healthy and even has some risk of bankruptcy.
TM has a better Altman-Z score (1.72) than 81.08% of its industry peers.
A Debt/Equity ratio of 0.64 indicates that TM is somewhat dependend on debt financing.
TM has a Debt to Equity ratio (0.64) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF N/A
Altman-Z 1.72
ROIC/WACC1.66
WACC3.22%
TM Yearly LT Debt VS Equity VS FCFTM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10T 20T 30T

2.3 Liquidity

A Current Ratio of 1.27 indicates that TM should not have too much problems paying its short term obligations.
With a Current ratio value of 1.27, TM perfoms like the industry average, outperforming 56.76% of the companies in the same industry.
TM has a Quick Ratio of 1.11. This is a normal value and indicates that TM is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.11, TM is in the better half of the industry, outperforming 72.97% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 1.11
TM Yearly Current Assets VS Current LiabilitesTM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10T 20T 30T

3

3. Growth

3.1 Past

TM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -11.70%.
Measured over the past years, TM shows a quite strong growth in Earnings Per Share. The EPS has been growing by 19.57% on average per year.
TM shows a small growth in Revenue. In the last year, the Revenue has grown by 4.45%.
The Revenue has been growing by 9.97% on average over the past years. This is quite good.
EPS 1Y (TTM)-11.7%
EPS 3Y20.57%
EPS 5Y19.57%
EPS Q2Q%-34.79%
Revenue 1Y (TTM)4.45%
Revenue growth 3Y15.25%
Revenue growth 5Y9.97%
Sales Q2Q%3.51%

3.2 Future

Based on estimates for the next years, TM will show a decrease in Earnings Per Share. The EPS will decrease by -4.62% on average per year.
The Revenue is expected to grow by 3.01% on average over the next years.
EPS Next Y-30.6%
EPS Next 2Y-9.43%
EPS Next 3Y-4.62%
EPS Next 5YN/A
Revenue Next Year3.27%
Revenue Next 2Y3.05%
Revenue Next 3Y3.01%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
TM Yearly Revenue VS EstimatesTM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 10T 20T 30T 40T 50T
TM Yearly EPS VS EstimatesTM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1K 2K 3K

6

4. Valuation

4.1 Price/Earnings Ratio

TM is valuated reasonably with a Price/Earnings ratio of 8.99.
TM's Price/Earnings ratio is rather cheap when compared to the industry. TM is cheaper than 94.59% of the companies in the same industry.
TM's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.20.
TM is valuated reasonably with a Price/Forward Earnings ratio of 9.91.
TM's Price/Forward Earnings ratio is rather cheap when compared to the industry. TM is cheaper than 83.78% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.71, TM is valued rather cheaply.
Industry RankSector Rank
PE 8.99
Fwd PE 9.91
TM Price Earnings VS Forward Price EarningsTM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, TM is valued cheaper than 91.89% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.67
TM Per share dataTM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150 200 250

4.3 Compensation for Growth

The excellent profitability rating of TM may justify a higher PE ratio.
TM's earnings are expected to decrease with -4.62% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.46
EPS Next 2Y-9.43%
EPS Next 3Y-4.62%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.29%, TM has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.27, TM pays a better dividend. On top of this TM pays more dividend than 91.89% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.38, TM pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.29%

5.2 History

On average, the dividend of TM grows each year by 14.07%, which is quite nice.
TM has paid a dividend for at least 10 years, which is a reliable track record.
TM has decreased its dividend in the last 3 years.
Dividend Growth(5Y)14.07%
Div Incr Years2
Div Non Decr Years2
TM Yearly Dividends per shareTM Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50 100 150 200

5.3 Sustainability

TM pays out 27.58% of its income as dividend. This is a sustainable payout ratio.
DP27.58%
EPS Next 2Y-9.43%
EPS Next 3Y-4.62%
TM Yearly Income VS Free CF VS DividendTM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2T 4T
TM Dividend Payout.TM Dividend Payout, showing the Payout Ratio.TM Dividend Payout.PayoutRetained Earnings

TOYOTA MOTOR CORP -SPON ADR

NYSE:TM (9/16/2025, 8:04:00 PM)

After market: 200 +1.22 (+0.61%)

198.78

+1.5 (+0.76%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)08-07 2025-08-07/dmh
Earnings (Next)11-04 2025-11-04/amc
Inst Owners24.68%
Inst Owner Change-4.28%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap259.08B
Analysts77.86
Price Target203.41 (2.33%)
Short Float %0.09%
Short Ratio2.06
Dividend
Industry RankSector Rank
Dividend Yield 3.29%
Yearly Dividend5.77
Dividend Growth(5Y)14.07%
DP27.58%
Div Incr Years2
Div Non Decr Years2
Ex-Date09-29 2025-09-29 (45)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.78%
Min EPS beat(2)7.7%
Max EPS beat(2)11.86%
EPS beat(4)3
Avg EPS beat(4)13.09%
Min EPS beat(4)-41.93%
Max EPS beat(4)74.75%
EPS beat(8)7
Avg EPS beat(8)17.77%
EPS beat(12)9
Avg EPS beat(12)13.82%
EPS beat(16)13
Avg EPS beat(16)14.33%
Revenue beat(2)1
Avg Revenue beat(2)0.54%
Min Revenue beat(2)-0.47%
Max Revenue beat(2)1.55%
Revenue beat(4)2
Avg Revenue beat(4)0.69%
Min Revenue beat(4)-0.66%
Max Revenue beat(4)2.33%
Revenue beat(8)5
Avg Revenue beat(8)2.64%
Revenue beat(12)9
Avg Revenue beat(12)3.25%
Revenue beat(16)13
Avg Revenue beat(16)3.35%
PT rev (1m)7.91%
PT rev (3m)3.65%
EPS NQ rev (1m)-2.41%
EPS NQ rev (3m)-25.16%
EPS NY rev (1m)-22.72%
EPS NY rev (3m)-22.91%
Revenue NQ rev (1m)0.91%
Revenue NQ rev (3m)-3.38%
Revenue NY rev (1m)0.59%
Revenue NY rev (3m)0.13%
Valuation
Industry RankSector Rank
PE 8.99
Fwd PE 9.91
P/S 0.79
P/FCF N/A
P/OCF 7.79
P/B 1.06
P/tB 1.1
EV/EBITDA 7.67
EPS(TTM)22.12
EY11.13%
EPS(NY)20.07
Fwd EY10.09%
FCF(TTM)-0.59
FCFYN/A
OCF(TTM)25.52
OCFY12.84%
SpS252.91
BVpS188.12
TBVpS181.01
PEG (NY)N/A
PEG (5Y)0.46
Profitability
Industry RankSector Rank
ROA 4.57%
ROE 11.86%
ROCE 7.25%
ROIC 5.35%
ROICexc 7.12%
ROICexgc 7.32%
OM 9.6%
PM (TTM) 8.82%
GM 19.29%
FCFM N/A
ROA(3y)4.63%
ROA(5y)4.34%
ROE(3y)12.12%
ROE(5y)11.36%
ROIC(3y)4.89%
ROIC(5y)4.54%
ROICexc(3y)6.18%
ROICexc(5y)5.68%
ROICexgc(3y)6.34%
ROICexgc(5y)17.96%
ROCE(3y)7.22%
ROCE(5y)6.72%
ROICexcg growth 3Y-39.12%
ROICexcg growth 5Y5.29%
ROICexc growth 3Y7.2%
ROICexc growth 5Y5.36%
OM growth 3Y1.5%
OM growth 5Y4.44%
PM growth 3Y2.98%
PM growth 5Y7.79%
GM growth 3Y1.57%
GM growth 5Y2.05%
F-Score6
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF N/A
Debt/EBITDA 3.33
Cap/Depr 224.58%
Cap/Sales 10.33%
Interest Coverage 2.83
Cash Conversion 71.06%
Profit Quality N/A
Current Ratio 1.27
Quick Ratio 1.11
Altman-Z 1.72
F-Score6
WACC3.22%
ROIC/WACC1.66
Cap/Depr(3y)219.04%
Cap/Depr(5y)219.3%
Cap/Sales(3y)10.7%
Cap/Sales(5y)11.63%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-11.7%
EPS 3Y20.57%
EPS 5Y19.57%
EPS Q2Q%-34.79%
EPS Next Y-30.6%
EPS Next 2Y-9.43%
EPS Next 3Y-4.62%
EPS Next 5YN/A
Revenue 1Y (TTM)4.45%
Revenue growth 3Y15.25%
Revenue growth 5Y9.97%
Sales Q2Q%3.51%
Revenue Next Year3.27%
Revenue Next 2Y3.05%
Revenue Next 3Y3.01%
Revenue Next 5YN/A
EBIT growth 1Y-16.01%
EBIT growth 3Y16.98%
EBIT growth 5Y14.86%
EBIT Next Year19576.8%
EBIT Next 3Y484.63%
EBIT Next 5YN/A
FCF growth 1Y73.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y37.77%
OCF growth 3Y-0.23%
OCF growth 5Y9.04%